Single‐cell RNA sequencing to explore cancer‐associated fibroblasts heterogeneity: “Single” vision for “heterogeneous” environment
Cell Proliferation · 2024-05 · 57 (5)
DOI: 10.1111/cpr.13592 ↗At a glance
Übersichtsarbeit in Cell Proliferation, published online on 2023-12-29. Written by Xiangjian Zhang and 5 co-authors. Institution: The Dingli Clinical College of Wenzhou Medical University, Wenzhou, Zhejiang, China. Major MEDLINE topics: Cancer-Associated Fibroblasts, Single-Cell Analysis, Sequence Analysis, RNA, Tumor Microenvironment. Cited 34 times so far (Crossref); 149 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, Natural Science Foundation of Shanghai Municipality, Science and Technology Plan Project of Wenzhou Municipality.
Abstract (original language)
Cancer‐associated fibroblasts (CAFs), a phenotypically and functionally heterogeneous stromal cell, are one of the most important components of the tumour microenvironment. Previous studies have consolidated it as a promising target against cancer. However, variable therapeutic efficacy—both protumor and antitumor effects have been observed not least owing to the strong heterogeneity of CAFs. Over the past 10 years, advances in single‐cell RNA sequencing (scRNA‐seq) technologies had a dramatic effect on biomedical research, enabling the analysis of single cell transcriptomes with unprecedented resolution and throughput. Specifically, scRNA‐seq facilitates our understanding of the complexity and heterogeneity of diverse CAF subtypes. In this review, we discuss the up‐to‐date knowledge about CAF heterogeneity with a focus on scRNA‐seq perspective to investigate the emerging strategies for integrating multimodal single‐cell platforms. Furthermore, we summarized the clinical application of scRNA‐seq on CAF research. We believe that the comprehensive understanding of the heterogeneity of CAFs form different visions will generate innovative solutions to cancer therapy and achieve clinical applications.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- The Dingli Clinical College of Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Department of Surgical Oncology, Wenzhou Central Hospital, Wenzhou, Zhejiang, China.
- The Second Affiliated Hospital of Shanghai University, Wenzhou, Zhejiang, China.
- Interventional Cancer Institute of Chinese Integrative Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- School of Medicine, Shanghai University, Shanghai, China.
- Institute of Translational Medicine, Shanghai University, Shanghai, China.
ORCID profiles: Ke Xu
Funding
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai Municipality
- Science and Technology Plan Project of Wenzhou Municipality
- Shanghai Pudong New Area Science and Technology Development Fund for the People's Livelihood Research Project
Cite
APA
Zhang, X., Zhu, R., Yu, D., Wang, J., Yan, Y., & Xu, K. (2024). Single‐cell RNA sequencing to explore cancer‐associated fibroblasts heterogeneity: “Single” vision for “heterogeneous” environment. Cell Proliferation, 57(5). https://doi.org/10.1111/cpr.13592
Vancouver
Zhang X, Zhu R, Yu D, Wang J, Yan Y, Xu K. Single‐cell RNA sequencing to explore cancer‐associated fibroblasts heterogeneity: “Single” vision for “heterogeneous” environment. Cell Proliferation. 2024;57(5). doi:10.1111/cpr.13592
BibTeX
@article{Zhang2024,
author = {Zhang, Xiangjian and Zhu, Ruiqiu and Yu, Die and Wang, Juan and Yan, Yuxiang and Xu, Ke},
title = {Single‐cell RNA sequencing to explore cancer‐associated fibroblasts heterogeneity: “Single” vision for “heterogeneous” environment},
journal = {Cell Proliferation},
year = {2024},
volume = {57},
number = {5},
doi = {10.1111/cpr.13592}
}
EUVIMED